2023 ICD-10-CM Diagnosis Code E70.338

Other albinism with hematologic abnormality

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
  • E70.338 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2023 edition of ICD-10-CM E70.338 became effective on October 1, 2022.
  • This is the American ICD-10-CM version of E70.338 - other international versions of ICD-10 E70.338 may differ.
The following code(s) above E70.338 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
  • Applicable To annotations, or
  • Code Also annotations, or
  • Code First annotations, or
  • Excludes1 annotations, or
  • Excludes2 annotations, or
  • Includes annotations, or
  • Note annotations, or
  • Use Additional annotations
that may be applicable to E70.338:
  • E00-E89
    2023 ICD-10-CM Range E00-E89

    Endocrine, nutritional and metabolic diseases

    Note
    • All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
    Type 1 Excludes
    • transitory endocrine and metabolic disorders specific to newborn (P70-P74)
    Endocrine, nutritional and metabolic diseases
  • E70-E88
    2023 ICD-10-CM Range E70-E88

    Metabolic disorders

    Type 1 Excludes
    • androgen insensitivity syndrome (E34.5-)
    • congenital adrenal hyperplasia (E25.0)
    • hemolytic anemias attributable to enzyme disorders (D55.-)
    • Marfan's syndrome (Q87.4)
    • 5-alpha-reductase deficiency (E29.1)
    Type 2 Excludes
    • Ehlers-Danlos syndromes (Q79.6-)
    Metabolic disorders
ICD-10-CM E70.338 is grouped within Diagnostic Related Group(s) (MS-DRG v40.0):
  • 642 Inborn and other disorders of metabolism

Convert E70.338 to ICD-9-CM

Code History
  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change

Diagnosis Index entries containing back-references to E70.338:
  • Albinism, albino E70.30
    ICD-10-CM Diagnosis Code E70.30

    Albinism, unspecified

      2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
    • with hematologic abnormality E70.339
      ICD-10-CM Diagnosis Code E70.339

      Albinism with hematologic abnormality, unspecified

        2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
      • other specified E70.338

ICD-10-CM Codes Adjacent To E70.338
E70.318 Other ocular albinism
E70.319 …… unspecified
E70.32 Oculocutaneous albinism
E70.320 Tyrosinase negative oculocutaneous albinism
E70.321 Tyrosinase positive oculocutaneous albinism
E70.328 Other oculocutaneous albinism
E70.329 …… unspecified
E70.33 Albinism with hematologic abnormality
E70.330 Chediak-Higashi syndrome
E70.331 Hermansky-Pudlak syndrome
E70.338 Other albinism with hematologic abnormality
E70.339 …… unspecified
E70.39 Other specified albinism
E70.4 Disorders of histidine metabolism
E70.40 …… unspecified
E70.41 Histidinemia
E70.49 Other disorders of histidine metabolism
E70.5 Disorders of tryptophan metabolism
E70.8 Other disorders of aromatic amino-acid metabolism
E70.81 Aromatic L-amino acid decarboxylase deficiency
E70.89 Other disorders of aromatic amino-acid metabolism

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.